Frankfurt-am-Main, Germany

Gilbert Muller


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gilbert Muller: Innovator in Growth Hormone Assessment

Introduction

Gilbert Muller is an eminent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of medical assessment, particularly with his focus on growth hormone deficiency. With a unique approach and an innovative patent to his name, Muller continues to push the boundaries of medical diagnostics.

Latest Patents

Muller holds a patent for a "Method of assessing growth hormone deficiency in humans by a macimorelin containing composition." This invention provides a novel method for measuring growth hormone levels in both human and animal subjects. The method also specifically assesses pituitary-related growth hormone deficiency following oral administration of macimorelin. This advancement is pivotal for accurate diagnostics and treatment of growth hormone deficiencies.

Career Highlights

Gilbert Muller is affiliated with Aeterna Zentaris GmbH, a company known for its dedication to developing therapeutics for unmet medical needs. His work at the company has enabled him to refine and promote his inventions in the pharmaceutical landscape. Muller’s focus on growth hormone research demonstrates his commitment to enhancing health outcomes through innovative solutions.

Collaborations

Throughout his career, Muller has collaborated with notable colleagues, including Nicola Ammer and Richard Sachse. These partnerships in research and innovation play a crucial role in advancing their collective expertise, benefiting product development and enhancing the efficacy of their contributions to medical science.

Conclusion

In conclusion, Gilbert Muller stands out as a significant innovator in the field of growth hormone assessment. His patent emphasizes the importance of precise diagnostics, with the potential to improve treatment protocols in endocrinology. As he continues his work at Aeterna Zentaris GmbH, Muller’s contributions are likely to lead to further breakthroughs in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…